Use of 2,5-dihydroxbencene sulfonic acid (dobesilate) for the treatment of age-related macular degeneration
申请人:Outeirino Miguez, Luis Antonio
公开号:EP2777699A1
公开(公告)日:2014-09-17
The invention relates to the safety and efficacy of Dobesilate, a very well known pharmaceutical composition, used as intravitreal injection in patients with age-related macular degeneration.